نتائج البحث

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study).

• Authors : Takamori S; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Notame, Minami-ku, Fukuoka, Japan.; Ohba T

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Biomarkers/Biomarkers/Biomarkers/*metabolism ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy

• Source: PloS one [PLoS One] 2021 Oct 22; Vol. 16 (10), pp. e0258616. Date of Electronic Publication: 2021 Oct 22 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.

• Authors : Sun X; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.

Subjects: Biomarkers/Biomarkers/Biomarkers/*metabolism ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*blood

• Source: BMC cancer [BMC Cancer] 2021 Jul 04; Vol. 21 (1), pp. 775. Date of Electronic Publication: 2021 Jul 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.

• Authors : Kamimaki C; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Kobayashi N

Subjects: Biomarkers/Biomarkers/Biomarkers/*metabolism ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use

• Source: Thoracic cancer [Thorac Cancer] 2021 Jun; Vol. 12 (11), pp. 1726-1734. Date of Electronic Publication: 2021 May 04.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Progression-free survival assessed per immune-related or conventional response criteria, which is the better surrogate endpoint for overall survival in trials of immune-checkpoint inhibitors in lung cancer: A systematic review and meta-analysis.

• Authors : Zhu GL; Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Sun Yat-sen University, Institute of Otorhinolaryngology Head and Neck Surgery, Sun Yat-sen University, Guangzhou, P. R. China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.

Subjects: Biomarkers*; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*drug therapy

• Source: Cancer medicine [Cancer Med] 2021 Dec; Vol. 10 (23), pp. 8272-8287. Date of Electronic Publication: 2021 Oct 20.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors.

• Authors : Pu D; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Xu Q

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use

• Source: Thoracic cancer [Thorac Cancer] 2021 Nov; Vol. 12 (21), pp. 2914-2923. Date of Electronic Publication: 2021 Sep 28.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients.

• Authors : Pescarmona R; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Laboratoire d'immunologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Subjects: Viral Load*; Biomarkers/Biomarkers/Biomarkers/*analysis ; DNA Virus Infections/DNA Virus Infections/DNA Virus Infections/*virology

• Source: PloS one [PLoS One] 2021 Aug 09; Vol. 16 (8), pp. e0255972. Date of Electronic Publication: 2021 Aug 09 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors.

• Authors : Jia XH; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Geng LY

Subjects: Biomarkers/Biomarkers/Biomarkers/*metabolism ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*diagnosis ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*adverse effects

• Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Dec 14; Vol. 39 (1), pp. 284. Date of Electronic Publication: 2020 Dec 14.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

تفاصيل العنوان

Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies.

• Authors : Hernandez C; Oncoimmunology Group, Biomedical Research Centre Navarrabiomed-UPNA, IdISNA, Irunlarrea 3, 31008 Pamplona, Spain.; Arasanz H

Subjects: Biomarkers* ; Blood Cells*; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use

• Source: International journal of molecular sciences [Int J Mol Sci] 2020 Mar 31; Vol. 21 (7). Date of Electronic Publication: 2020 Mar 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers.

• Authors : Li, Xiaomi^1,2 (AUTHOR); Tong, Li¹ (AUTHOR); Wang, Shan³ (AUTHOR)

• Source: BMC Medicine. 9/11/2024, Vol. 22 Issue 1, p1-15. 15p.

تفاصيل العنوان

Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors.

• Authors : Chen, Yi-Chao¹ (AUTHOR); Zheng, Wei-Zhong² (AUTHOR); Liu, Chun-Peng³ (AUTHOR)

• Source: Cancer Cell International. 9/10/2024, Vol. 24 Issue 1, p1-13. 13p.

تفاصيل العنوان